This protocol is judged by an institutional review board, an impartial group that critiques any medical trials involving human beings. If a review entails a Schedule I drug, when the board approves the protocol as ethical, the researchers really have to apply for an investigational new drug (IND) range from the FDA.Shoppers noted very little split